{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "10853849", "DateCompleted": {"Year": "2000", "Month": "10", "Day": "18"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "22"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0903-1936", "JournalIssue": {"Volume": "15", "Issue": "5", "PubDate": {"Year": "2000", "Month": "May"}}, "Title": "The European respiratory journal", "ISOAbbreviation": "Eur Respir J"}, "ArticleTitle": "Effects of azithromycin on ozone-induced airway neutrophilia and cytokine release.", "Pagination": {"StartPage": "856", "EndPage": "862", "MedlinePgn": "856-62"}, "Abstract": {"AbstractText": ["Exposure of humans to ozone causes increased neutrophils and inflammatory cytokines in airway lining fluid. Recent research shows that macrolide antibiotics may reduce interleukin (IL)-8 production by bronchial epithelial cells and inhibit neutrophil chemotaxis. A double-blind, cross-over study was performed in which 12 healthy subjects underwent two separate 4-h exposures to 0.2 parts per million ozone while exercising intermittently. In the 73.5 h before exposure, subjects were pretreated with either 1,250 mg azithromycin or placebo. Sputum induction conducted 74 h pre- and 18 h post-exposure was used to measure total cells, per cent neutrophils, IL-6, and IL-8. There were significant (p<0.05) pre- to post-exposure increases in total cells, neutrophils, IL-6 and IL-8 in both the azithromycin and placebo arms. However, no significant differences were found between azithromycin and placebo conditions in the post- minus pre-exposure value for these variables. The results suggest that in healthy subjects, in the design used, azithromycin, in usual clinical doses, does not have anti-inflammatory effects on human airways as indicated in the measured variables."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Lung Biology Center, Dept of Medicine, University of California, San Francisco 94143-0854, USA."}], "Identifier": [], "LastName": "Criqui", "ForeName": "G I", "Initials": "GI"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Solomon", "ForeName": "C", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Welch", "ForeName": "B S", "Initials": "BS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ferrando", "ForeName": "R E", "Initials": "RE"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Boushey", "ForeName": "H A", "Initials": "HA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Balmes", "ForeName": "J R", "Initials": "JR"}], "GrantList": [{"GrantID": "NIH/SCOR/P50HL56385", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Clinical Trial", "Controlled Clinical Trial", "Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Eur Respir J", "NlmUniqueID": "8803460", "ISSNLinking": "0903-1936"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-6"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-8"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "83905-01-5", "NameOfSubstance": "Azithromycin"}, {"RegistryNumber": "EC 1.11.1.7", "NameOfSubstance": "Peroxidase"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Azithromycin"}, {"QualifierName": [], "DescriptorName": "Cross-Over Studies"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["analysis", "biosynthesis"], "DescriptorName": "Interleukin-6"}, {"QualifierName": ["analysis", "biosynthesis"], "DescriptorName": "Interleukin-8"}, {"QualifierName": ["physiology"], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Neutrophils"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["analysis", "biosynthesis"], "DescriptorName": "Peroxidase"}, {"QualifierName": [], "DescriptorName": "Spirometry"}, {"QualifierName": ["chemistry", "cytology"], "DescriptorName": "Sputum"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "6", "Day": "15", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "10", "Day": "21", "Hour": "11", "Minute": "1"}, {"Year": "2000", "Month": "6", "Day": "15", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10853849", "10.1034/j.1399-3003.2000.15e08.x"]}}], "PubmedBookArticle": []}